Phreesia Total Liabilities 2019-2024 | PHR

Phreesia total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Phreesia Annual Total Liabilities
(Millions of US $)
2024 $119
2023 $82
2022 $77
2021 $63
2020 $57
2019 $64
2018 $0
Phreesia Quarterly Total Liabilities
(Millions of US $)
2024-04-30 $119
2024-01-31 $119
2023-10-31 $110
2023-07-31 $93
2023-04-30 $90
2023-01-31 $82
2022-10-31 $77
2022-07-31 $78
2022-04-30 $78
2022-01-31 $77
2021-10-31 $71
2021-07-31 $65
2021-04-30 $58
2021-01-31 $63
2020-10-31 $68
2020-07-31 $63
2020-04-30 $61
2020-01-31 $57
2019-10-31 $53
2019-07-31 $60
2019-04-30 $0
2019-01-31
2018-10-31 $0
2018-07-31 $0
2018-01-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.177B $0.356B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.257B 19.36
Tempus AI (TEM) United States $5.669B 0.00
Hims & Hers Health (HIMS) United States $4.401B 0.00
Inspire Medical Systems (INSP) United States $3.980B 0.00
Axonics (AXNX) United States $3.445B 0.00
Olink Holding AB (publ) (OLK) Sweden $3.202B 0.00
IRhythm Technologies (IRTC) United States $3.010B 0.00
Azenta (AZTA) United States $2.800B 157.42
Enovis (ENOV) United States $2.438B 18.07
10x Genomics (TXG) United States $2.234B 0.00
Privia Health (PRVA) United States $2.022B 113.00
Schrodinger (SDGR) United States $1.461B 0.00
Omnicell (OMCL) United States $1.229B 42.48
Standard BioTools (LAB) United States $0.682B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Clover Health Investments (CLOV) United States $0.621B 0.00
Fulgent Genetics (FLGT) United States $0.596B 0.00
Health Catalyst (HCAT) United States $0.365B 0.00
Talkspace (TALK) United States $0.365B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.305B 0.00
Pulmonx (LUNG) United States $0.245B 0.00
Butterfly Network (BFLY) United States $0.209B 0.00
Outset Medical (OM) United States $0.199B 0.00
TruBridge (TBRG) United States $0.168B 9.02
P3 Health Partners (PIII) United States $0.157B 0.00
American Well (AMWL) United States $0.089B 0.00
111 (YI) China $0.088B 0.00
EUDA Health Holdings (EUDA) Singapore $0.080B 0.00
SHL Telemedicine (SHLT) Israel $0.075B 0.00
HeartBeam (BEAT) United States $0.071B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
MSP Recovery (LIFW) United States $0.057B 0.00
Augmedix (AUGX) United States $0.049B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.048B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
CareCloud (CCLD) United States $0.032B 0.00
Streamline Health Solutions (STRM) United States $0.031B 0.00
Movano (MOVE) United States $0.031B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Biotricity (BTCY) United States $0.007B 0.00
Transgenomic (PRPO) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00